According to filings with the U.S. Securities and Exchange Commission, Innovein is raising $11,923,800.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, David Hovda played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Innovein
Over 10% of the US/EU suffers from bad valves in the veins of legs and advanced vein disease, with no option for valve replacement. Innovein, a Y Combinator and VC backed medical device company, addresses this unmet medical need with a first-in-class replacement valve for veins. Innovein has been awarded by Forbes, the Medical Device and Diagnostic Industry, MIT (CHIEF), and many others. In aggregate, the founding team of three has invented and brought over 15 medical devices to market, selling over $3B. They are addressing the multi-billion dollar unmet need of vein disease and successfully oversubscribed target financing. Awards: Forbes 30 under 30 – from over 15,000 nominations Innovation Award of the Year – Award rate < 4% – UCSF Rosenman Institute MIT (CHIEF) Business Competition – Diamond Award Recipient – Over 200 applicants Giant Partners Top 100 Startups Winner – AIM startup competition and Angellist Prize Medtechs Rising Star – Medical Device and Diagnostic Industry #1 Top Trending Deal – Angellist July 2016 #1 Top Listed Company on Angellist June 2017 (From over 3,000,000 companies) Accelerators: Y Combinator – Acceptance rate < 2% StartX Med – Acceptance rate < 8% For more information about Innovein email: info (at) innoveinmedical (dot) com .

To learn more about Innovein, visit http://www.innoveinmedical.com/

Contact:
David Hovda, Chief Executive Officer
707-695-1236

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.